CASP3 and Parkinson disease: In the MPTP model of PD, systemic treatment with Q-VD-OPh reduces DA cell death and spares TH positive fibers in the striatum when low doses of MPTP are used [70], potentially by preventing caspase-3-mediated apoptosis of nigral dopaminergic neurons [71].